This topic contains a solution. Click here to go to the answer

Author Question: A patient is in the clinic for a follow-up examination after a myocardial infarction (MI). The ... (Read 18 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
A patient is in the clinic for a follow-up examination after a myocardial infarction (MI). The patient has a history of left ventricular systolic dysfunction. The primary care NP should expect this patient to be taking:
 
  a. nadolol (Corgard).
  b. carvedilol (Coreg).
  c. timolol (Blocadren).
  d. propranolol (Inderal).

Question 2

An 80-year-old patient with chronic stable angina has begun taking nadolol (Corgard) 20 mg once daily in addition to taking nitroglycerin as needed. After 1 week, the patient reports no change in frequency of nitroglycerin use.
 
  The primary care nurse practitioner (NP) should change the dose of nadolol to _____ mg _____ daily. a. 40; once
  b. 80; once
  c. 20; twice
  d. 40; twice



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cpetit11

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

B
The 2012 guides for prevention of cardiovascular disease recommend that B-blocker therapy should be used in all patients with left ventricular systolic dysfunction with heart failure or prior MI. Use should be limited to carvedilol, metoprolol succinate, or bisoprolol.

Answer to Question 2

A
B-Blockers are the treatment of choice for chronic stable and unstable angina. Their therapeutic effect is dose dependent, and drug titration should be based on frequency of angina symptoms and nitroglycerin use. Nadolol should be started at 20 mg daily for elderly patients when treating angina and should be increased by 20 mg every 3 to 7 days if symptoms do not improve. Nadolol is given once daily.




Mr. Wonderful

  • Member
  • Posts: 866
Reply 2 on: Jul 24, 2018
Excellent


ttt030911

  • Member
  • Posts: 315
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

For a complete list of videos, visit our video library